james hebrew
@jameshebrewjames hebrew
I have been on the internet lately, looking for something to read and that is how I came across your site and saw this article of yours. So, I decided to see what it says and I find out that it is so amazing. You really did great work on your site... moreI have been on the internet lately, looking for something to read and that is how I came across your site and saw this article of yours. So, I decided to see what it says and I find out that it is so amazing. You really did great work on your site and the articles you posted on it. You really take your time in writing this article and they are clearly detailed
as the articles on the site <a href="www.rootsanalysis.com">rootsanalysis</a>. Please check the report <a href="https://www.rootsanalysis.com/reports/protein-design-and-engineering-market.html">Protein design</a> less
Updates
Info
Personal Information
- First Name james
- Last Name hebrew
- Gender Male
Albums
Forum Phot
Forum Phot
Forum Phot
Forum Phot
Forum Phot
Forum Phot
Forum Phot
Forum Phot
Forum Posts
-
Posted in the topic Digital Biomanufacturing market Analysis and Trends by 2022-2035 in the forum TechnologyMay 24, 2023 2:50 AM EDT
The “Digital Biomanufacturing Market, 2023-2035” report features an extensive study of various type of technologies, such as PAT, DAS, MES and digital twins offered by digital biomanufacturing providers.
Key Inclusions
- A general introduction to digital biomanufacturing, featuring a detailed discussion on various types of technologies that support digital bioprocessing. In addition, it presents the key challenges and future perspectives associated with the employment of digital technologies in the field of biomanufacturing.
- A detailed assessment of the overall market landscape of companies offering digital biomanufacturing technologies (PAT, DAS, MES and digital twins), based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, type of company (CDMO provider and software provider), number of platforms offered, deployment options (cloud based, on-premises, corporate datacenter and hybrid), platform capabilities (process automation, bioprocess optimization and controls, process connectivity, scalability, data integration, process monitoring and visualization, performance analysis, report generation and documentation, smart manufacturing, document control, production tracking, performance analysis and data integration), software capabilities (process intelligence, data integration, real-time process monitoring, data visualization, performance analysis and control prediction, reporting and data management), type(s) of biologic(s) manufactured, other compatible platforms (artificial intelligence / machine learning / cloud based, big data, internet of things, augmented reality and virtual reality) and type of end user(s) (industry and non-industry), integrating software (enterprise resource planning (ERP), manufacturing operation management (MOM), product lifecycle management (PLM), human resource management (HRM)), type of service(s) offered (training, implementation / upgradation and general support), area(s) of application (asset / process management, clinical trials, personalized treatment, medical training, surgical planning, health monitoring and diagnosis).
- A detailed competitiveness analysis of digital biomanufacturing technologies (PAT, DAS, MES and digital twins), based on supplier strength (in terms of years of experience and company size), technology portfolio (considering deployment options, number of platform capabilities, type of end user(s), software capabilities, area(s) of application, type(s) of twin(s)) and type(s) of biologic(s) manufactured.
- Elaborate profiles of key players (companies offering more than one platform and established before 2012) engaged in the digital biomanufacturing domain, which are actively providing software based on PAT, DAS, MES and digital twins. Each profile includes a brief overview of the company, along with information on capabilities of digital technologies offered by these firms, recent developments and an informed future outlook.
- A benchmark analysis highlighting the capabilities of companies (in terms of their expertise across various platforms related to the manufacturing of biologics) engaged in this domain, across key peer groups.
- An analysis featuring information on recent partnerships inked between stakeholders engaged in this domain, based on several relevant parameters, such as year of partnership, type of partnership, type of technology, most active players (in terms of number of deals inked) and regional distribution of partnership activity, during the period 2018-2022.
- A detailed analysis highlighting the market concentration of key industry stakeholders (companies offering more than one platform) across various regions, based on prevalent parameters, such as years of entrance, company size, type of technology, number of platforms offered and number of partnerships inked.
- A detailed industry lifecycle analysis that indicates various stages, including emergence, growth, maturation and eventual decline for the digital biomanufacturing industry. The primary purpose of this analysis is to develop a better understanding of the current position / phase of the industry on the lifecycle chart (based on historical trends, partnership activity and various investments made by players engaged in this domain) and predict the upcoming events that are likely to drive the growth of this domain. Further, it presents short-term and long-term impacts of various key parameters that are expected to highly impact the wider adoption of digitalization in the field of biomanufacturing.
.
The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:
- Type of Technology
- Process Analytical Technology (PAT)
- Data Analysis Software (DAS)
- Manufacturing Execution Systems (MES)
- Digital Twins
- Deployment Options
- Cloud-based Deployment Options
- On-premises Deployment Options
- Type(s) of Biologic(s) Manufactured
- Antibodies
- Cell and Gene Therapies
- Proteins
- Vaccines
- Others
- Geographical Regions
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and North America
Key Questions Answered
- What is the global market size of digital biomanufacturing?
- Which are the top players in the global digital biomanufacturing market?
- What are the factors driving the digital biomanufacturing market?
- Which region has the highest market share in the global digital biomanufacturing market?
- What are the leading market segments in digital biomanufacturing market?
- Which segment, in terms of deployment options, accounts for the largest share in the global digital biomanufacturing market?
- What are the partnership and collaboration trends in the digital biomanufacturing domain?
- What is the growth rate (CAGR) in the global digital biomanufacturing market?
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/digital-biomanufacturing-market.html
You may also be interested in the following titles:
Pharmaceutical Polymers / Medical Polymers Market
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
#DigitalBiomanufacturingMarket #DigitalBiomanufacturingMarketSize #DigitalBiomanufacturing #bioprocesssimulationsoftware #bioprocessing4.0
-
Posted in the topic mRNA Synthesis and Manufacturing Services market in the forum TechnologyMay 22, 2023 3:54 AM EDT
The “mRNA Synthesis and Manufacturing Services Market (2nd Edition), 2022-2035” report an extensive study of the current market landscape and future potential of the mRNA synthesis and contract manufacturing service market.
Key Inclusions
- A general overview of mRNA, highlighting details on its structure and the historical evolution of mRNA vaccines. It also presents information on the in-vitro synthesis of mRNA, its applications in various therapeutic modalities and the challenges associated with the process. Additionally, it features a discussion on the commonly outsourced manufacturing operations and their advantages.
- A detailed assessment of the overall market landscape of the companies offering mRNA custom synthesis services, based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, type of service(s) offered (custom synthesis, modification, purification, process development, scale-up / manufacturing and fill / finish), input for synthesis (plasmid DNA, mRNA sequence, PCR fragments and other(s)), structural modification (3’ modification, 5’ modification and base modification), type of purification method(s) (precipitation, chromatography, electrophoresis and other(s)), application area(s) (research and therapeutics / vaccines), scale of operation (research / preclinical, clinical, and commercial) and GMP compliance. It also features information on the mRNA synthesis / manufacturing capacity of the mRNA custom synthesis service providers, highlighting the length of the mRNA manufactured.
- A detailed competitiveness analysis of mRNA custom synthesis service providers based on supplier strength (in terms of years of experience) and service strength (considering type of service(s) offered, type of modification, scale of operation, GMP compliance and application areas).
- A comprehensive assessment of the overall market landscape of mRNA contract manufacturing service providers, based on several relevant parameters, including year of establishment, company size (in terms of number of employees), location of headquarters, location of manufacturing facilities, type of product(s) manufactured (drug products (FDFs) and drug substances (APIs)), type of service(s) offered (fill / finish, formulation development, purification, process development, analytical testing, and regulatory support) and scale of operation (research / preclinical, clinical and commercial).
- An in-depth company competitiveness analysis of mRNA contract manufacturing service providers based in North America, Europe and Asia-Pacific.The analysis compares the contract service providers based on supply strength (in terms of years of experience) and service portfolio strength (considering type of service(s) offered, scale of operation, type of product manufactured and number of facilities).
- A detailed overview of the current market landscape of kits available for mRNA synthesis, based on several relevant parameters, such as type of enzyme, kit components, type of enzyme mix used, mRNA component modified, yield per reaction, number of reactions, reaction run time and kit price. It also features a list of players engaged in the development of mRNA kits, along with analysis based on year of establishment, company size (in terms of number of employees) and location of headquarters. Additionally, it highlights the leading players (in terms of number of mRNA synthesis kits offered) in this domain.
- A product competitiveness analysis of the mRNA synthesis kits, based on supplier power (in terms of the experience of the developer) and product competitiveness (in terms of type of enzyme, number of kit component(s), type of mRNA component modified, yield, number of reaction(s) and price).
- Elaborate profiles of key players engaged in the synthesis and manufacturing of mRNA (shortlisted based on strength of service portfolio). Each profile includes a brief overview of the company, along with information on mRNA synthesis service portfolio, additional services offered, recent developments and an informed future outlook.
- Detailed profiles of the key mRNA synthesis kit providers (shortlisted based on strength of product portfolio). Each profile includes a brief overview of the company, along with information on the mRNA synthesis kits portfolio.
- An analysis of completed, ongoing and planned clinical studies of mRNA therapeutics and vaccines, based on several relevant parameters, such as trial registration year, trial status, trial phase, target patient population, therapeutic area, type of sponsor / collaborator, leading industry players (in terms of number of trials conducted), and regional distribution of trials.
- A detailed analysis of the recent partnerships inked between stakeholders engaged in this domain, since 2014, covering acquisitions, manufacturing agreements, fill / finish service agreements, supply agreements, service alliance, and other relevant deals.
- An in-depth analysis of over 35 mRNA-based therapeutics / vaccines developers that are likely to partner with mRNA contract manufacturing service providers. These players have been shortlisted based on several relevant parameters, such as developer strength (which takes into account the company’s experience), company size, (in terms of number of employees), pipeline strength (based on the number of mRNA-based drugs in pipeline), highest phase of development, therapeutic area, route of administration and type of candidate being developed.
- A review of the various mRNA-focused initiatives undertaken by big pharma players (shortlisted on the basis of the revenues generated in 2021), featuring various insightful representations, such as Harvey ball analysis, spider web analysis, based on several relevant parameters such as funding amount raised, partnership activity, and diversity of product portfolio (in terms of disease indication(s) being treated and focus therapeutic area(s)).
- A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
- Type of Product
- Drug substances (APIs)
- Drug products (FDFs)
- Application Area
- mRNA-based vaccines
- mRNA-based therapeutics
- Therapeutic Area
- Infectious diseases
- Oncological disorders
- Other diseases
- Key Geographical Regions
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and North Africa
- Rest of the World
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/mrna-synthesis-and-manufacturing-market.html
You may also be interested in the following titles:
Decentralized Clinical Trials / Virtual Clinical Trials Market
You may also like to learn what our experts are sharing in Roots educational series:
Cell Therapy – The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders
4D Bioprinting Market: Key Trends
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
#mRNASynthesisandManufacturingServicesMarket #mRNASynthesisandManufacturingServicesMarketSize #mRNAsynthesisservices #mRNAsynthesisandmanufacturingservices #mRNAbasedproducts
-
Posted in the topic Cell and gene therapy CRO market in the forum TechnologyMay 19, 2023 5:34 AM EDT
Characterized by high prevalence rate of rare and genetic disorders, and rise in demand for effective novel ATMPs, the cell and gene therapy contract research industry is likely to witness evolutionary advancements, in the coming years
Roots Analysis is pleased to announce the publication of its recent study, titled, “Cell and Gene Therapy CROs Market, 2022-2035”.
The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:
- A detailed overview of the overall market landscape of the cell and gene therapy CROs, based on several relevant parameters, such as year of establishment, company size, location of headquarters, area of expertise, scale of operation and types of services offered.
- A detailed analysis on the business models that are commonly adopted by the biopharmaceutical industry for outsourcing cell and gene therapies.
- Elaborate profiles of key industry players based in North America, Europe and Asia-Pacific that offer contract research services.
- A benchmark analysis of the various players engaged in this domain. It highlights the capabilities of the companies.
- An analysis of the recent collaborations within the cell and gene therapy contract research industry, during the period 2015-2022.
- A detailed analysis of the various mergers and acquisitions that have taken place in this domain, during the period 2015-2022.
- A detailed acquisition target analysis, taking into consideration historical trend of the activity of players that have acquired other firms since 2015.
- A detailed discussion on affiliated trends, key drivers and challenges, under a SWOT framework, which are likely to impact the industry’s evolution highlighting the relative effect of each SWOT parameter on the overall cell and gene therapies research services industry.
- A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
- Area of Expertise
- Cell Therapy
- Gene Therapy
- Scale of Operation
- Preclinical
- Clinical
- Drug Discovery
- Therapeutic Area
- Oncological Disorders
- Neurological Disorders
- Cardiovascular Disorders
- Infectious Diseases
- Metabolic Disorders
- Autoimmune Disorders
- Blood Disorders
- Rare / Genetic Disorders
- Ophthalmic Disorders
- Other disorders
- Analysis by Geographical Regions
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and North Africa
Key companies covered in the report
- Altasciences
- Charles River Laboratories
- Creative Biolabs
- IQVIA
- Medpace
- PPD
- Precision for Medicine
- Accelera
- Evotec
- ICON
- Syneos Health
- CMIC Group
- Labcorp
To view more details on this report, click on the link:
https://www.rootsanalysis.com/reports/view_document/cell-and-gene-therapy-cros-market/230.html
You may also be interested in the following titles:
Cell Therapy Manufacturing Market
You may also like to learn what our experts are sharing in Roots educational series:
CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com#CellandgenetherapyCROMarket #CellandgenetherapyCROMarketGrowth #Geneandcelltherapy #cellandgenetherapycro #cellandgenetherapies
-
Posted in the topic Artificial Intelligence in Oncology market in the forum TechnologyMay 17, 2023 2:42 AM EDT
Over time, significant strides have been made to carry out research to explore the benefits of artificial intelligence.
Further, several AI technologies are being investigated for the early treatment and diagnosis of cancer. Overall, this domain is anticipated to gain significant traction, in the foreseen future. The AI in oncologymarket is dominated by companies based in North America; of these majority were established post 2010. The financial opportunity within the Artificial Intelligence in Oncology market has been analyzed across the following segments:
- Type of Cancer
- Solid Malignancies
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Colorectal Cancer
- Brain Tumor
- Others
- Hospitals
- Pharma Companies
- Research Institutes
- Others
- North America
- Europe
- Asia Pacific
- Rest of the World
- Type of End-User
- Key Geographical Regions
The Artificial Intelligence in Oncology Market, 2022-2035,report features the following companies, which we identified to be key players in this domain:
- Ibex Medical Analytics
- Niramai
- Optellum
- Tempus Labs
- Paige
- Kheiron Medical Technologies
Table of Contents
1. Preface
2. Executive Summary
3. Introduction4. Market Overview
5. Company Profiles
6. Company Competitiveness Analysis
7. Patent Analysis
8. Partnerships
9. Funding and Investment Analysis
10. Blue Ocean Strategy: A strategic guide for start-ups to enter into highly competitive market
11. Market Forecast and Opportunity Analysis
12. Conclusion
13. Executive Insights
14. Appendix 1: Tabulated Data
15. Appendix 2: List of Companies and Organizations
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/ai-in-oncology-market.html
You may also be interested in the following titles:
Oral Proteins and Peptides Market
Deep Learning in Drug Discovery Market and Deep Learning in Diagnostics Market
You may also like to learn what our experts are sharing in Roots educational series:
Liposomes Development: Service Providers Landscape
mRNA Synthesis: Manufacturing Process of Modern Revolutionary Molecule
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
#AutomaticSamplingMarket #AutomaticSamplingMarketSize #automaticsamplinginbiopharmaceuticals #asepticsampling #samplingmarket
-
Posted in the topic Bacteriophage therapeutics market 2022 – Industry Growth by 2035 in the forum TechnologyMay 15, 2023 3:35 AM EDT
With the ever-increasing burden of antimicrobial resistance, the focus of the research community has shifted towards the development of alternatives for the treatment of infectious diseases.
One of such alternatives is bacteriophage therapeutics. The innovators suggests that the success of these therapies lies in the effectiveness of phages to target the desired bacterial strains.
The financial opportunity within the bacteriophagetherapeutics market has been analyzed across the following segments:
- Type of Therapeutic Area
- Infectious Diseases
- Oncological Disorders
- Other Disorders
- Distribution by Route of Administration
- Oral Route
- Rectal Route
- Intravesical Route
- Topical Route
- Key Geographical Regions
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and North Africa
The “Bacteriophage Therapy Market, 2022-2035” report features the following companies, which we identified to be key players in this domain:
- Adaptive Phage Therapeutics
- ContaFect
- Eliava BioPreparations
- Micreos
- NPO Microgen
- Phagelux
- Pherecydes Pharma
Table of Content
- PREFACE
- EXECUTIVE SUMMARY
- INTRODUCTION
4. BACTERIOPHAGE THERAPY: MARKET LANDSCAPE
5. BACTERIOPHAGE THERAPEUTICS: DEVELOPER LANDSCAPE
- COMPANY AND DRUG PROFILES
- CLINICAL TRIAL ANALYSIS
- PATENT ANALYSIS
- PUBLICATION BENCHMARKING ANALYSIS
- ACADEMIC GRANTS ANALYSIS
- FUNDING AND INVESTMENT ANALYSIS
12. PARTNERSHIPS AND COLLABORATIONS
- START-UP HEALTH INDEXING
14. MARKET FORECAST AND OPPORTUNITY ANALYSIS
- CONCLUSION
- EXECUTIVE INSIGHTS
- APPENDIX I: TABULATED DATA
- APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
For additional details, please visit https://www.rootsanalysis.com/reports/bacteriophage-therapy-market.html
You may also be interested in the following titles:
Pharmaceutical Polymers / Medical Polymers Market
You may also like to learn what our experts are sharing in Roots educational series:
T-cell Immunotherapies: The Future of Modern Cancer Treatments
Monkeypox: Disease Overview, Transmission and Diagnosis
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
#Bacteriophagetherapeuticsmarket #Bacteriophagetherapeuticsmarketsize #bacteriophage #phage# bacteriophagetherapy
